| By Marketwire . | Article Rating: |
|
| January 8, 2013 10:37 AM EST | Reads: |
250 |
STOCKTON, CA -- (Marketwire) -- 01/08/13 -- Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the addition of Mort Rothbard MD to its Advisory Board.
Morton Rothbard MD, PhD was the Founder of In-Shape City Health Clubs (Inshapeclubs.com), with over 65 Athletic Clubs in the USA. He was awarded the recognition as "Business Man of the Year" in the city of Stockton, California.
Dr. Rothbard received his Bachelor of Science from Syracuse University, his Master's degree from Northeastern University in 1954, and his PhD in Bio-Chemistry in 1957 from Notre Dame. He received his MD from St. Louis University in 1962, with his Internship at Jewish Hospital of St. Louis, and Residency in Urology at NYU, Bellevue Hospital New York and at Stanford, Stanford Presbyterian Hospital in San Francisco. He has published an article in the Journal of Cancer.
Dr. Rothbard did his post-Doctoral research at the University of Wisconsin McArdle Cancer Labs, with a special interest in cancer. He practiced urology for about 20 years. Then he started a business chain of health clubs. "I am interested in the overall health of people and new technologies for health," stated Dr. Rothbard, "I do have a special interest in cancer, not only because of my past research in this field, also from my private practice experience. With my background in Biochemistry, I understand the Viratech interest in health maintenance, which was my interest in the health and fitness industry and its ability to reach hundreds of thousands, and not simply hundreds of people in a medical office, that is why I started health clubs many years ago."
"Dr. Rothbard's expertise in cancers of the bladder, kidney, and prostate, due to his background in urology and biochemistry, is very complementary to Viratech's interests in early screening of these cancers," states Dr. Buckman, CEO of Viratech.
About Viratech Corp.
Based in Stockton, California, Viratech Corp., which just announced its acquisition of Cancer.im, https://www.youtube.com/watch?v=dz1tHRb3wvU, has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced. This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech's open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech's micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact:
Kevin Buckman MD
Viratech, Corp.
http://viratech.org
Email Contact: Email Contact
Tel: 209 477 3030
Published January 8, 2013 Reads 250
Copyright © 2013 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By Marketwire .
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.
- Cloud People: A Who's Who of Cloud Computing
- Cloud Expo New York: Cloud Is Changing the Economics of Business
- Windows Azure IaaS Reaches General Availability
- Portable Experimenter’s Platform, Powered by Raspberry Pi
- Cloudant to Exhibit at Cloud Expo & Big Data Expo New York
- Learn How To Use Google Apps Script
- Cloud Computing Is Simplifying Things
- Cloud Expo New York: Basics of SSD Technology and Its Use in Cloud
- Cloud Expo New York: The Big Challenge of Big Data & Hadoop Integration
- Overview of the OpenStack Cloud
- Session Topics: 12th Cloud Expo / Cloud Expo New York
- The Flexible Cloud
- Cloud People: A Who's Who of Cloud Computing
- Cloud Expo New York: Cloud Is Changing the Economics of Business
- Cloud Expo New York: How to Use Google Apps Script
- Windows Azure IaaS Reaches General Availability
- Rackspace Hosting Named “Platinum Plus Sponsor” of Cloud Expo New York
- Portable Experimenter’s Platform, Powered by Raspberry Pi
- Small Cancers, Big Data, and a Life Examined
- SUSE Receives Common Criteria Security Certifications
- Basho Announces Open Source Riak CS and General Availability of Riak CS Enterprise v1.3
- Cloudant to Exhibit at Cloud Expo & Big Data Expo New York
- Learn How To Use Google Apps Script
- VMware Sets Up New Hybrid Cloud Unit
- After Ubuntu, Windows Looks Increasingly Bad, Increasingly Archaic, Increasingly Unfriendly
- SCO CEO Posts Open Letter to the Open Source Community
- Simula Labs Launches Hosted Delivery Platform To Enable Enterprise Open Source Adoption
- Where Are RIA Technologies Headed in 2008?
- Source Claims SCO Will Sue Google
- How Open Is "Open"? – Industry Luminaries Join the Debate
- Latest SCO News is Plain Weird
- SCO Claims Linux Lifted ELF
- IBM Tells SCO Court It Can't Find AIX-on-Power Code
- Developing an Application Using the Eclipse BIRT Report Engine API
- Should RIM BlackBerries Be Rented?
- Flashback: Investing in 'Professional Open Source' - Exclusive 2004 Interview with David Skok, Matrix Partners


























